Analysis of approval times of anticancer drugs

There has been a significant increase in marketing authorisa-tion approvals of anticancer drugs in the EU. We performed an analysis over the period 2010-2017 to investigate which factors impact the approval time of anti-cancer products and compared this to data from a similar analysis by Hartmann et al covering 2006-2011.

read the full abstract here

Meet up on LinkedIn
Zwiers Regulatory Consultancy is a ProductLifeGroup Company

ProductLife Group’s mission is to improve human health by delivering regulatory & compliance services for the safe and effective use of medical solutions. PLG supports clients through the entire product life cycle, combining local expertise with global reach spanning more than 150 countries.

Product LIfe Group